|
|
The current role of radiofrequency ablation in the treatment of hepatocellular carcinoma |
Wan Yee Lau and Stephanie Hiu Yan Lau |
Hong Kong, China
Author Affiliations: Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China (Lau WY and Lau SHY)
Corresponding Author: Professor Wan Yee Lau, MD, FRCS, FACS, FRACS(Hon), Professor of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China (Tel: +852-2632-2626; Fax: +852-2632-5459; Email: josephlau@cuhk.edu.hk) |
|
|
Abstract Local ablative therapy is used in treating liver tumors by either injection of cytotoxic agents (chemicals, radioactive isotopes, hyperthermic agents or chemotherapeutic agents) or application of an energy source to achieve thermal ablation, cryoablation or conformal external beam radiation (Table 1).
|
|
|
|
|
|
|
|